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	 In	 mammals,	 fertilization	 is	 a	 well-orchestrated	
event	culminating	in	the	union	of	two	highly	specialized	
cells	 i.e.,	 the	 spermatozoon	 and	 the	 egg.	 Binding	
of	 sperm	 after	 going	 through	 a	 series	 of	 changes	 in	
female	 reproductive	 tract,	 termed	 ‘capacitation’,	 to	
the	zona	pellucida	(ZP)	of	the	oocyte	is	an	important	
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Background & objectives: An inability or decreased ability of spermatozoa to bind to the zona pellucida 
(ZP), an extracellular glycoproteinaceous matrix surrounding egg, is one of the plausible causes of 
idiopathic infertility. It will be clinically useful to distinguish this condition from other causes of infertility. 
An assay system, investigating binding of human sperm with ZP glycoprotein may prove useful in this 
regard. We attempted to develop a simple assay system to analyse the binding of capacitated human 
spermatozoa to human zona pellucida glycoprotein-3 (ZP3) using baculovirus-expressed recombinant 
human ZP3 coated beads.
Methods: Recombinant baculovirus-expressed ZP3 was purified, labelled with biotin and coated on 
streptavidin sepharose beads. An in vitro assay system was optimized to study binding of capacitated 
human sperm to ZP3 coated beads. 
Results: A higher percentage of baculovirus-expressed recombinant human ZP3 coated beads showed 
significant (P<0.05) binding of capacitated human sperm as compared to beads coated with fetuin. An 
inhibition in the binding of sperm to ZP3 coated beads was observed in presence of cold recombinant 
human ZP3. Further, prior incubation of ZP3 coated beads with monoclonal antibodies (MAbs) against 
ZP3 but not against ZP2 resulted in the decrease in number of sperm bound to bead.
Interpretation & conclusion: An in vitro assay system to study the binding of human sperm to ZP3-
primary sperm receptor was established, which may be useful to determine the functional competence 
of spermatozoa.
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step	 for	 successful	 fertilization.	 ZP	 not	 only	 plays	
a	crucial	 role	 in	 fertilization	by	serving	as	a	 species-
selective	substrate	for	sperm	binding	but	also	acts	as	an	
agonist	for	regulated	exocytosis	of	the	spermatozoon’s	
acrosomal	 vesicle1.	 Inability	 or	 decreased	 ability	 of	
spermatozoa	 binding	 to	 the	 ZP	 is	 considered	 as	 one	
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of	the	plausible	causes	of	idiopathic	infertility.	It	may	
be	clinically	useful	 to	distinguish	this	condition	from	
other	causes	of	infertility2.
	 The	 ZP	 in	 mammals	 is	 composed	 of	 3	 to	 4	
biochemically	 distinct	 highly	 sulphated	 glycoproteins.	
The	ZP	matrix	of	mice,	pigs	and	rabbits	is	comprised	of	
3	glycoproteins	whereas	4	glycoproteins	constitute	the	
ZP	matrix	of	rats,	monkeys	and	humans3-5.	In	humans,	
these	glycoproteins	have	been	designated	as	ZP1,	ZP2,	
ZP3	and	ZP4.	In	mice	as	well	as	humans,	ZP3	has	been	
shown	 to	be	 the	primary	sperm	receptor6-8.	Our	group	
has	reported	expression	of	recombinant	human	ZP3	in	
prokaryotic	 (Escherichia coli)	 and	 eukaryotic	 (insect	
cells	 using	baculovirus	 expression)	 system7.	Both	non	
glycosylated	 and	 glycosylated	 forms	 of	 recombinant	
human	ZP3	binds	to	the	anterior	head	of	the	capacitated	
human	spermatozoa8.	No	binding	of	recombinant	human	
ZP3	however,	was	observed	in	the	anterior	head	region	of	
the	acrosome	reacted	spermatozoa8.	Our	group	has	also	
reported the development of highly specific monoclonal 
antibodies	 (MAbs)	 against	 recombinant	 human	 ZP3,	
which	 recognize	 native	 human	ZP39.	 Employing,	 one	
of the specific MAb against recombinant human ZP3, 
recently purification of native human ZP3 from human 
egg	 has	 been	 successfully	 achieved10.	Binding	 studies	
employing purified native human ZP3 revealed similar 
binding profile as baculovirus-expressed recombinant 
human	ZP311.
	 In	 the	 present	 study,	 employing	 baculovirus-
expressed	 recombinant	 human	 ZP3	 coated	 on	
streptavidin	 sepharose	beads,	we	developed	 a	 simple	
assay	 system	 for	 analysis	 of	 binding	 of	 capacitated	
human spermatozoa to ZP3. In addition, the efficacy of 
the ZP3 specific MAbs to inhibit binding of sperm to 
ZP3	coated	sepharose	beads	has	also	been	evaluated.
Material & Methods
Purification of baculovirus-expressed recombinant 
human ZP3 and its biotinylation:	Cloning	and	expression	
of	 recombinant	 human	 ZP3	 (aa	 residues	 1-424)	 as	
polyhistidine	tagged	fusion	protein	in	the	baculovirus-
expression	 system	 has	 been	 reported	 earlier7.	 For	
large	 scale	 production	 of	 the	 recombinant	 protein,	 a	
suspension	culture	of	50	X	106	Spodoptera frugiperda 
(Sf21)	 insect	 cells	 (BD	Pharmingen,	San	Diego,	CA,	
USA)	 growing	 in	 a	 Spinner	 bottle	 (Thermolyne,	
Barnstead	 International,	 Iowa,	 USA)	 was	 incubated	
with	 the	 ZP3	 recombinant	 virus	 at	 a	 multiplicity	 of	
infection	(MOI)	of	3	at	42	rotations	per	minute	(rpm)	
on	a	biological	stirrer	 (Thermolyne	Cellgro,	USA)	at	
27°C.	After	96	h	of	incubation,	cells	were	pelleted	at	
1000	 ×	g for 15 min, and recombinant ZP3 purified 
using	Ni-NTA	resin	(Qiagen	GmbH,	Hilden,	Germany)	
as	 described	 previously7. The purified recombinant 
protein	 in	 20	 mM	 Tris	 (pH	 7.4)	 was	 assessed	 for	
protein	 concentration	 using	 bicinchoninic	 acid	 assay	
(BCA;	Pierce,	Rockford,	IL,	USA)	using	bovine	serum	
albumin	 (BSA;	 Sigma-Aldrich	 Inc.,	 St.	 Louis,	 MO,	
USA)	as	the	standard.	
 For biotinylation, 1 mg of the purified ZP3 or 
Fetuin	(taken	as	negative	control	in	the	study;	Sigma-
Aldrich	 Inc.	 USA)	 was	 extensively	 dialyzed	 against	
biotin	 labelling	buffer	(0.1	M	NaHCO3,	0.1	M	NaCl,	
pH	 8.0)	 and	 conjugated	 to	 NHS-LC-biotin	 (Pierce,	
USA).	The	NHS-LC-biotin	used	here	had	spacer	arm	
of	 13.5 Ǻ. The conjugation reaction was performed 
at	 room	 temperature	 (RT)	 for	 1	 h	 by	 incubating	 the	
protein	with	freshly	prepared	NHS-LC-biotin	at	a	1:20	
molar	ratio,	with	end-to-end	shaking.	Post-incubation,	
unreacted	sites	were	blocked	with	0.2	M	glycine	in	0.1	
M	NaHCO3,	0.1	M	NaCl,	pH	8.0,	for	30	min	at	RT	and	
the	 biotin	 labelled	 protein	 was	 extensively	 dialyzed	
against	 dialysis	 buffer	 (0.1	M	Tris,	 0.2	M	NaCl,	pH	
8.0)	 for	 24	 h.	 The	 concentration	 of	 the	 biotinylated	
protein	was	determined	by	BCA.	To	assess	the	quality	
of	 biotinylated	 ZP3,	 it	 was	 resolved	 on	 0.1	 per	 cent	
SDS-	10	per	cent	PAGE	followed	by	Commassie	blue	
staining	as	described	previously7.	In	addition,	resolved	
protein	was	processed	 for	Western	blot	analysis	after	
transferring	protein	to	nitrocellulose	membrane	of	0.45	
µm	(Advanced	Microdevices	Pvt	Ltd.,	Ambala	Cantt,	
India),	 employing	 avidin-HRPO	 conjugate	 (1:3000;	
Pierce),	as	described	elsewhere7.
Coating of streptavidin sepharose beads with biotinylated 
recombinant human ZP3 and fetuin: Streptavidin	sepharose	
beads (6% beads suspension, mean particle size 34 μm, 
25	µl;	GE	Healthcare	Biosciences	AB,	Uppsala,	Sweden)	
were	 washed	 twice	 with	 0.1	 M	 Tris,	 150	 mM	 NaCl	
(pH	 7.4;	 TBS)	 and	 incubated	 with	 varying	 amount	 of	
biotinylated	ZP3	at	RT	for	2	h	with	intermittent	shaking.	
In	 addition,	 sepharose	beads	were	 incubated	with	BSA	
or	biotinylated	fetuin	as	negative	controls	under	similar	
conditions.	After	incubation,	coated	beads	were	pelleted	
at	1000	×	g,	washed	twice	with	TBS,	resuspended	in	100	
µl	of	TBS	and	stored	at	4ºC	till	further	use.	Coating	of	
recombinant human ZP3 on beads was confirmed by 
Western	blot	as	described	above.	
Human spermatozoa and capacitation: All	experiments	
using	 human	 spermatozoa	 were	 carried	 out	 after	
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informed	consent	and	following	the	clearance	from	the	
Institutional	Bio-safety	and	Human	Ethical	Committees.	
Semen	samples	were	collected	from	healthy	voluntary	
donors	and	subjected	to	liquefaction	at	RT	for	30	min.	
Aliquots	(0.5	ml)	of	semen	were	layered	over	a	 two-
step	 Percoll	 density	 gradient12.	 The	 gradient	 layered	
with	semen	was	centrifuged	at	500	x	g	for	30	min	at	
RT.	 The	 pellets	 comprising	 of	 >90	 per	 cent	 motile	
spermatozoa	were	pooled	and	washed	thrice	with	5	ml	
of	 Biggers-Whitten-Whittingham	 medium13	 (BWW;	
pH	7.4)	supplemented	with	0.3	per	cent	BSA	(Sigma	
Aldrich	Inc.,	embryo	 tested)	by	centrifugation	at	500	
×	g	for	10	min.	The	sperm	pellet	was	resuspended	in	
BWW	medium	supplemented	with	2.6	per	cent	BSA	at	
a	concentration	of	10	×	106	sperm/ml	and	incubated	in	
aliquots	of	1	ml	for	6	h	at	37°C in a humidified chamber 
with	5	per	cent	CO2	in	air	for	capacitation.	
Binding of ZP3 or fetuin coated beads with capacitated 
human sperm: ZP3	or	fetuin	coated	beads	suspension	
(20 μl/reaction) was washed once with 500 µl of BWW 
medium	and	resuspended	in	25	µl	of	BWW	medium	+	
0.3	per	cent	BSA.	To	the	ZP3	coated	bead	suspension,	
capacitated	human	sperm	(1	×	106)	in	25	µl	of	BWW	
medium	+	0.3	per	cent	BSA	were	added	and	incubated	
at	37°C in humidified chamber with 5 per cent CO2	for	
15	min	followed	by	30	min	at	4°C.	After	 incubation,	
500	µl	of	BWW	medium	+	0.3	per	cent	BSA	was	added	
to	the	reaction	mixture	and	beads	were	centrifuged	at	
50	×	g	for	2	min	at	25°C.	Supernatant	was	discarded	
to	remove	unbound	sperm.	Pellet	was	resuspended	in	
100	 µl	 of	 3	 per	 cent	 glutaraldehyde	 (Sigma	Aldrich	
Inc.)	 in	 50	 mM	 PBS,	 pH	 7.4,	 and	 incubated	 at	 RT	
for 40 min for fixing of the spermatozoa bound to 
beads.	After	incubation,	beads	were	washed	once	with	
PBS	 and	 spotted	 on	 clean	 glass	 slides	 and	 number	
of	 sperm	 bound	 to	 the	 coated	 beads	 were	 counted	
microscopically	 (Nikon,	 Chiyoda-ku,	 Tokyo,	 Japan)	
under bright field using 40X objective. In	 all	 the	
binding	 experiments,	 at	 least	 100	 beads	were	 scored	
for	 each	 reaction	 and	 the	 experiment	 was	 repeated	
four-five times with semen sample from three different 
male	donors	to	rule	out	any	ambiguity.	For	each	group,	
the	percentage	of	beads	showing	binding	with	sperm	
were	 determined	 by	 counting	 the	 number	 of	 beads	
showing	binding	with	one	or	more	capacitated	sperm.	
Number	of	 sperm	bound	per	 bead	was	 calculated	by	
total	number	of	bound	 sperm	divided	by	 the	number	
of counted beads in different fields. Additionally, data 
have	 been	 convoluted	 to	 represent	 number	 of	 sperm	
bound	per	bead	showing	binding	of	sperm.
 To study the specificity of binding of spermatozoa 
with	 ZP3,	 ZP3	 or	 fetuin	 coated	 beads,	 were	 pre-
incubated with varying amounts of purified ZP3 
specific MAbs generated as described previously9.	ZP3	
coated beads pre-incubated with human ZP2 specific 
MAbs	 served	 as	 an	 internal	 control.	 Subsequently,	
these	beads	were	washed	once	with	50	mM	PBS	and	
used	for	binding	of	sperm	as	described	above.	
Statistical analysis: Results	were	expressed	as	mean	±	
SEM	of	4-5	different	experiments	using	semen	samples	
from	 at	 least	 three	 different	 donors.	 The	 statistical	
analysis	was	done	by	comparing	the	means	of	the	either	
uncoated	or	fetuin	coated	beads	with	ZP3	coated	beads	
group	or	within	two	different	experimental	groups	by	
using	one	way	ANOVA	followed	by	Newmans-Keuls	
multiple	 comparison	 test	 employing	 CCSTAT	Quick	
Statistics	For	Optometrist	(Version	3.5,	India).	P<0.05	
was considered to be statistically significant. 
Results
Characterization of biotinylated baculovirus-expressed 
recombinant human ZP3: To	 study	 the	 interaction	of	
human	ZP3	with	capacitated	spermatozoa,	baculovirus-
expressed recombinant human ZP3 was purified by Ni-
NTA affinity chromatography and labelled with NHS-
LC-biotin.	The	analysis	of	biotinylated	ZP3	by	SDS-
PAGE	and	Western	blot	revealed	a	prominent	band	of	
~56	kDa	(Fig.	1a	and	1b	respectively).
Binding of capacitated human sperm with ZP3 coated 
beads: Streptavidin	 sepharose	 beads	 coated	with	 2,	 5,	
10	and	25	µg	of	biotinylated	recombinant	human	ZP3	
were	 employed	 to	 study	 the	 binding	 of	 capacitated	
human spermatozoa. Significantly higher number of ZP3 
coated	 beads	 as	 compared	 to	 uncoated	 beads	 or	 fetuin	
coated	 beads	 showed	 binding	 of	 capacitated	 human	
sperm	(P<0.05;	Table	I).	Not	only	the	higher	number	of	
ZP3	coated	beads	showed	sperm	binding	but	an	increase	
in	the	number	of	sperm	bound	per	ZP3	coated	bead	as	
compared	 to	 control	 beads	 was	 also	 observed.	 Beads	
coated	with	10	µg	of	biotinylated	ZP3	showed	optimum	
binding of sperm (Table I). A representative profile of 
ZP3	coated	bead	showing	binding	of	sperm	as	compared	
to	fetuin	coated	bead	is	shown	in	Fig.	2.	Majority	of	the	
sperm	showed	binding	of	 the	head	to	 the	recombinant	
ZP3-coated	 beads.	 Further	 optimization	 of	 the	 assay,	
employing	different	concentrations	of	ZP3	coated	beads	
revealed	 that	 0.096	 per	 cent	 bead	 suspension	 resulted	
in	optimum	binding	of	spermatozoa	to	the	beads	(Table	
II).	A	 positive	 correlation	 was	 seen	 between	 number	
of	beads	and	number	of	 sperm/bead	showing	binding.	
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Linear	regression	analysis	showed	that	up	to	0.144	per	
cent	of	stock	ZP3	beads	(~2100	beads),	sperm	binding	
increased in a linear fashion (Coefficient of Regression, 
r=0.9794;	Fig.	3).	Binding	of	capacitated	sperm	to	ZP3	
coated beads was specific as a decrease in the percentage 
of	beads	showing	sperm	binding	along	with	the	number	
of	sperm	bound	per	bead	was	observed	in	presence	of	
unlabelled	ZP3	(Table	III).		Further,	prior	incubation	of	
ZP3 coated beads with ZP3 specific MAbs (MA 1552 
and	MA	1558)	also	resulted	in	a	decrease	in	percentage	
of	beads	showing	sperm	binding,	number	of	sperm	bound	
per	coated	bead	along	with	number	of	sperm	bound	per	
bead	showing	sperm	binding	(Table	III).	However,	prior	
incubation of ZP3 coated beads with ZP2 specific MAbs 
(MA	1615)	did	not	result	in	any	decrease	in	the	binding	
of	sperm	to	beads	suggesting	that	binding	of	sperm	to	
ZP3 coated beads is specific. No alteration in the binding 
of	 sperm	 to	 fetuin	 coated	 beads	 was	 observed	 in	 the	
presence	of	various	monoclonal	antibodies	(Table	III).
Discussion
	 Several	 investigators	 have	 successfully	 studied	
sperm-ZP	interaction	employing	recombinant	proteins	in	
the	past	and	found	that	recombinant	human	ZP	proteins	
are	 functionally	 active7-8,14-16.	 In	 the	 present	 study,	
baculovirus-expressed	 recombinant	 human	 ZP3	 was	
employed	which	has	been	shown	to	have	both	N-	and	O-
linked	glycosylation	with	high	mannose	type	carbohydrate	
residues7.	 Native	 human	 zona	 proteins	 also	 have	 high	
mannose	 type	 carbohydrate	 residues17.	 Human	 sperm	
have	been	reported	to	harbour	mannose	binding	sites	on	
the	surface	that	have	been	implicated	to	play	a	crucial	role	
in	sperm-egg	interaction18-19.	Binding	studies	with	FITC	
labelled	baculovirus-expressed	recombinant	human	ZP3	
with	 capacitated	 human	 spermatozoa	 revealed	 similar	
binding	 characteristics	 as	 native	 human	 solubilized	
isolated	 zona	 suggesting	 that	 the	baculovirus-expressed	
recombinant	human	ZP3	can	be	used	to	develop	assays	
pertaining	to	ZP3-spermatozoa	interaction8.
Fig. 1. Analysis of purified recombinant human ZP3 conjugated 
to	 NHS-LC-biotin	 by	 SDS-PAGE	 and	Western	 blot. The purified 
baculovirus-expressed	 recombinant	human	ZP3	was	conjugated	 to	
NHS-LC-biotin,	 resolved	 by	 0.1	 per	 cent	 SDS-10	 per	 cent	 PAGE	
under	reducing	conditions	and	analyzed	by	Commassie	blue	staining	
(Panel	A)	&	Western	blot	(Panel	B)	using	avidin-HRPO	conjuagte	
(1:2K).	 Lanes	 are	 represented	 as	 M:	 Molecular	 weight	 markers;	
Lanes	1:	Baculovirus-expressed	recombinant	human	ZP3	conjugated	
to NHS-LC-biotin (5 μg/lane in Panel A and 2 μg/lane in Panel B).
Fig. 2. Representative profile of binding of capacitated human 
sperm	with	human	ZP3	coated	beads. Binding	of	the	capacitated	
human	 sperm	 to	 the	 baculovirus-expressed	 recombinant	 human	
ZP3	coated	streptavidin	sepharose	beads	along	with	fetuin	coated	
beads	used	as	negative	control,	was	carried	out.	Panel	A:	Binding	
of	 sperm	 to	 fetuin	 coated	 bead	 (negative	 control)	 and	 Panel	B:	
Binding of sperm to ZP3 (10 μg ZP3) coated bead.
Fig. 3.	Linear	 regression	 analysis	 of	 the	ZP3	bead	bound	 sperm	
as	a	function	of	the	number	of	beads	used	in	the	assay.	Different	
concentrations	of	ZP3	coated	beads	(0.048%,	~700	beads;	0.096,	
~1400	beads;	0.144%,	~2100	beads)	suspension	were	allowed	 to	
bind	with	1×106 capacitated human sperm. Regression coefficient 
was calculated by applying apparent linear fit to data on X-axis 
(number	of	ZP3	beads	used	in	the	assay)	and	Y-axis	(sperm/bead	
showing	binding)	on	linearized	scales.
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Table I. Binding	characteristics	of	capacitated	human	sperm	to	streptavidin	sepharose	beads	coated	with	biotinylated	baculovirus-expressed	
recombinant	human	ZP3
Experimental	conditions %	Beads	showing	sperm	
binding
No.	of	sperm	bound/coated	
bead
Sperm/bead	showing	binding
Streptavidin	sepharose	beads 8.2	±	0.9 0.09	±	0.01 1.17	±	0.03
Streptavidin	sepharose	
beads	coated	with																	10	µg
biotinylated	fetuin		
7.6	±	0.8* 0.08	±	0.01 1.07	±	0.03
Streptavidin	sepharose											2	µg	
beads	coated	with																			5	µg	
biotinylated	ZP3																			10	µg
																																														25	µg
29.6	±	2.8** 0.49	±	0.04 1.69	±	0.09
37.8	±	1.4** 0.63	±	0.03 1.67	±	0.07
41.5	±	1.4** 0.88	±	0.02 2.12	±	0.06
36.3	±	1.6** 0.79	±	0.04 2.20	±	0.08
Values	are	shown	as	mean ±	SEM	of	5	experiments
*P>0.05	as	compared	to	streptavidin	coated	beads;	**P<0.05	as	compared	to	streptavidin	coated	beads
Table II. Binding	characteristics	of	capacitated	human	sperm	to	different	concentrations	of	streptavidin	sepharose	beads	coated	with	10	µg	
biotinylated	baculovirus-expressed	recombinant	human	ZP3
Experimental	conditions Concentration	of		
coated	beads
(%)
%	Beads	showing	sperm	
binding
No.	of	sperm	bound/
coated	bead
Sperm/bead	showing	
binding
Streptavidin	sepharose	beads 0.06 7.9	±	1.2 0.11	±	0.03 1.36	±	0.13
Streptavidin	sepharose	beads	coated	
with	10	µg	biotinylated	fetuin
0.096 11.9	±	0.7 0.15	±	0.01 1.44	±	0.13
Streptavidin	sepharose												
beads	coated
with	10	µg												
biotinylated	ZP3	
0.048 27.6	±	1.2 0.54	±	0.03 1.95	±	0.03
0.096 38.4	±	0.7 1.19	±	0.01 3.11	±	0.05
0.144 27.3	±	2.9 0.98	±	0.07 3.66	±	0.13
0.192 33.3	±	1.7 0.64	±	0.05 1.89	±	0.07
Values	are	shown	as	mean	±	SEM	of	4	experiments
Table III.	Binding	characteristics	of	capacitated	human	sperm	to	biotinylated	recombinant	human	ZP3	coated	streptavidin	sepharose	beads	
in	presence	or	absence	of	inhibitors
Experimental	conditions Competitive	inhibitor	
in	equilibrium
%	Beads	showing	
sperm	binding
No.	of	sperm	bound/
coated	bead
Sperm/bead	showing	
binding
Streptavidin	sepharose	beads - 8.2	±	0.2 0.09	±	0.01 1.16	±	0.05
0.048%	Streptavidin	sepharose		
beads	coated	with	10	µg
biotinylated	fetuin
- 11.4	±	0.6 0.14	±	0.01 1.19	±	0.06
MA	1552*	
(10	µg/ml)
7.7	±	0.6 0.11	±	0.01 1.41	±	0.11
MA	1558*	
(10	µg/ml)
8.0	±	0.7 0.10	±	0.01 1.24	±	0.07
MA	1615*	
(10	µg/ml)
11.6	±	0.7 0.14	±	0.01 1.21	±	0.07
0.048%	Streptavidin	sepharose		
beads	coated	with	10	µg
biotinylated	ZP3
- 36.7	±	0.9 1.07	±	0.02 2.93	±	0.03
Unlabelled	ZP3	
(300	ng)
24.8	±	1.2 0.45	±	0.02 1.81	±	0.04
Unlabelled	ZP3	
(600	ng)
20.6	±	0.5 0.29	±	0.01 1.45	±	0.03
MA	1552*	
(2	µg/ml)
30.6	±	0.8 0.61	±	0.02 1.99	±	0.04
MA	1552*	
(10	µg/ml)
25.2	±	0.5 0.44	±	0.01 1.73	±	0.02
MA	1558*
(2	µg/ml)
21.1	±	0.8 0.36	±	0.02 1.69	±	0.03
MA	1558*	
(10	µg/ml)
21.3	±	1.1 0.35	±	0.02 1.62	±	0.02
MA	1615*	
(2	µg/ml)
36.7	±	0.7 1.05	±	0.02 2.86	±	0.02
MA	1615*	
(10	µg/ml)
34.3	±	0.8 0.98	±	0.04 2.84	±	0.06
*MA 1552 and MA 1558 have specificity for human ZP3 and MA 1615 for human ZP2; Values are mean ±	SEM	of	5	experiments
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	 Conventional	 semen	 analyses	 in	 the	 In Vitro	
Fertilization	 (IVF)	 clinics	 may	 not	 provide	 accurate	
information	about	sperm	fertilizing	ability	since	many	
patients	with	subtle	sperm	defects	cannot	be	detected20.	
More	 advanced	 and	 physiologically	 relevant	 sperm	
function	tests	are	required	to	detect	sperm	defects	that	
may	 lead	 to	 failure	 of	 fertilization	 in	 standard	 IVF.	
Sperm-ZP	binding	and	sperm-ZP	penetration	tests	have	
been	suggested	to	be	most	powerful	indicators	for	sperm	
fertilizing	ability	in vitro21.	Presently	available	functional	
tests	under	these	categories	include,	zona-free	hamster	
oocyte	sperm	penetration	test22,	hemizona	assay	(HZA)23	
and	the	hypoosmotic	swelling	(HOS)	test24.	
	 Zona-free	 hamster	 oocyte	 penetration	 test	 has	
been	developed	as	an	indicator	of	the	ability	of	human	
spermatozoa	 to	 capacitate,	 acrosome	 react	 and	 fuse	
with	the	vitelline	membrane	of	the	oocyte22.	However,	
some	 reports	 have	 suggested	 that	 assessment	 of	
sperm	fertilizing	capacity	using	this	test	does	not	have	
significant clinical benefit in diagnosing infertility25,26.	
Dead	or	immotile	spermatozoa	also	penetrate	zona-free	
hamster	eggs	under	certain	conditions26.	Furthermore,	this	
assay	is	time	consuming,	complex	and	subject	to	many	
variables	such	as	capacitation	time,	sperm	concentration	
and	 incubation	 conditions,	 medium	 composition	 and	
the	age	of	ovum	after	ovulation27.	Hemizona	assay	has	
an	 excellent	 predictive	 power	 for	 IVF	 outcome	 and	
for the identification of male infertility but it requires 
technical	expertise	to	use	expensive	micromanipulators	
to bisect native human oocyte, which are difficult to 
obtain	 owing	 ethical	 restrictions.	 The	 HOS	 test	 can	
predict	 the	 fertilizing	capacity	of	human	spermatozoa.	
A	 positive	 HOS	 test	 is	 an	 indicator	 of	 the	 functional	
integrity	of	the	sperm	membrane	as	judged	by	a	swollen	
head	 and	 curled	 tail	 of	 spermatozoa	when	 exposed	 to	
hypo-osmotic	conditions24.	However,	the	clinical	utility	
of	the	HOS	test	in	assessment	of	sperm	function	is	still	
debatable	 as	 there	 are	 contrasting	 reports	 regarding	
positive	correlation	between	HOS	and	IVF	outcome28.	
Therefore,	an	easy	as	well	as	reliable	tool	to	assess	the	
fertilizing	 potential	 of	 human	 spermatozoa	 will	 be	 of	
immense	help.
	 In	the	present	study,	after	characterizing	the	binding	
characteristics	 of	 baculovirus-expressed	 recombinant	
human	 ZP38,	 attempts	 were	 made	 to	 optimize	 an	 in 
vitro	assay	system	employing	biotinylated	baculovirus-
expressed	recombinant	human	ZP3	coated	on	streptavidin	
sepharose	 beads	 and	 capacitated	 human	 sperm.	 Size	
(mean paricle size 34 μm) of strepatavidin sepharose 
beads	 employed	 in	 the	 present	 study	 to	 coat	 human	
ZP3	 was	 close	 to	 human	 oocytes	 which	 may	 allow	
accessibility	of	ZP3	epitopes	for	binding	to	spermatozoa.	
Moreover,	previous	studies	from	our	group	have	shown	
that	biotinylated	recombinant	bonnet	monkey	(Macaca 
radiata)	ZP3	binds	with	anterior	head	of	the	capacitated	
spermatozoa	 and	 did	 not	 reveal	 any	 binding	 to	 the	
acrosome-reacted	spermatozoa29,	thereby	suggesting	that	
biotinylation	of	ZP3	does	not	result	 in	alteration	of	its	
biological	activity.	The	optimum	binding	of	capacitated	
sperm	to	ZP3	coated	beads	was	observed	when	beads	
were coated with 10 μg biotinylated ZP3/reaction. The 
decrease	in	the	binding	of	spermatozoa	to	beads	coated	
with higher amount of human ZP3 (25 μg ZP3/reaction) 
may	be	due	to	steric	hinderance.	Further,	dilution	curve	
with 10 μg ZP3 coated beads revealed a bead suspension 
of	0.096	per	cent	exhibiting	maximum	binding	of	sperm,	
which	may	be	attributed	to	the	optimization	of	beads	to	
spermatozoa	 ratio.	 Binding	 of	 Xenopus laevis	 sperm	
with purified vitelline envelope proteins coated on 
agarose	beads	have	been	reported	earlier30.	Binding	of	
porcine	 and	 bovine	 sperm	with	 baculovirus-expressed	
recombinant	 porcine	 ZP	 glycoproteins	 has	 also	 been	
studied	using	the	bead-binding	assay	format31.	In	murine	
model	ZP3	coated	silica	beads	have	been	used	to	study	
sperm-ZP3	 interaction.	 In	 this	 solid	 phase	 assay,	 only	
one	spermatozoa	was	observed	to	bind	per	ZP3-bead	via	
sperm	head32.
	 The	 observations	 that	 the	 binding	 of	 capacitated	
human	spermatozoa	to	ZP3	coated	beads	was	inhibited	
in	the	presence	of	ZP3	or	prior	incubation	of	ZP3	coated	
beads with ZP3 specific MAbs, strongly suggest that the 
binding of sperm to ZP3 coated beads is specific. This 
assay	being	simple,	low	cost	and	easy	to	handle	can	be	
used	effectively	in	IVF	clinics	to	check	the	functional	
competence	of	sperm	to	bind	with	ZP	of	human	egg.
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